Posts categorized as“Biotech”

Susan Bantroch

Consider these 3 areas carefully when testing medical devices in a Biolab

Keep your project on time, within budget  Testing medical devices in a Biolab often requires changing locations from an engineering lab to a Biosecurity Level 2 (BSL2) BioLab that can facilitate specialized tests involving potentially dangerous microorganisms, tissues and biological fluids. Careful pre-planning is required for timely experiments to take place in BSL2 BioLabs. Poorly […]

Chrystal Palaty

6 Commercialization insights from serial medtech entrepreneurs

Participant’s takeaways from 2019 Medical Device Playbook Medical Device Playbook was conceived as a way to inspire entrepreneurship and connect the many players in the Medical Device world. In seven words, I would describe this as an “informative and inspirational storytelling event, great people.” Medtech innovators and investors described their first-hand commercialization, partnership, regulatory, and […]

Brian Hanrahan

How Regenerative Medicine will transform therapeutic medical devices

50 years of research in stem cell biology, immunology, molecular biology, genomics, engineering and advanced materials, are transforming the therapeutic landscape much like antibiotics once did for infectious diseases.  Regenerative Medicine (RM) and advanced therapeutic products encompass a very diverse and broad range of approaches that enable the body to repair, replace, restore and regenerate […]

Meghan Robinson

Fighting acute lymphoblastic leukemia (ALL) with CAR-T regenerative medicine

Chimeric antigen receptor T-cell (CAR-T) therapy is a rising shining star in Regenerative Medicine.  Medical devices will be involved in many of the processes involved with CAR-T therapies. From blood collection, to T-cell isolation and activation, modification, expansion and product formulation, preconditioning and finally T-Cell infusion and delivery, there will be an evolution in the […]

Alexandra Reid

Double your biotech R&D budget

5 tips to a successful academic-industrial partnership Costs are rising for research so how do you maximize your biotech R&D budget? Form an academic-industrial partnership. Perhaps you are working on a disruptive technology and need an expert to assess that your assay is better than the accepted standard? Or maybe you’ve had a pet research […]

Nick Allan

Infectious diseases Point of Care assay industry trends

For insight into Infectious diseases Point of Care (POC) assay industry trends I’ve summarized several leading sources for trends including the World Health Organization, the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting key topics, and an Ipsos Mori poll published by the Bill and Melinda Gates Foundation.